Company Profile
HOOKIPA Pharma Inc. Stock Price, News & Analysis
- Ticker:
- HOOK
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.15 USD (+0.88%)
Close
Last updated: June 2, 2026
—
Market cap
Why the stock is moving
Current closing-price context is not available for HOOK.
Company overview
Business overview
Hookipa Pharma is a biopharmaceutical company focused on immunotherapy and oncology, with a strategy that has centered on viral-vector and immune-based platforms. Its business has been shaped by platform ambition and strategic resets.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Hookipa sits in specialty biotechnology.
Business Model Characteristics
The company depends on clinical validation, partnerships, and the ability to find a durable immune-therapy franchise.
Position Within the Biotechnology Landscape
Hookipa is a high-risk immunology name whose story depends heavily on platform and financing progress.
Future catalysts
HOOKIPA’s catalysts are HB-700 and the rest of its viro-immunotherapy platform, plus any partnership or strategic update. The market will care about whether the viral-immunotherapy thesis still has a path.
Recent news
- 01
HOOKIPA Pharma Announces Completion of Sale of Oncology Assets to NeoTrail Therapeutics
Source: HOOKIPA Pharma Inc.
- 02
HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics
Source: HOOKIPA Pharma Inc.
- 03
HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead
Source: HOOKIPA Pharma Inc.
- 04
HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock
Source: HOOKIPA Pharma Inc.
- 05
HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)
Source: HOOKIPA Pharma Inc.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of HOOKIPA Pharma Inc. (HOOK)?
HOOKIPA Pharma Inc. (HOOK) most recently closed at 1.15 USD, a +0.88% move versus the previous session.
What does HOOKIPA Pharma Inc. do?
Hookipa Pharma is a biopharmaceutical company focused on immunotherapy and oncology, with a strategy that has centered on viral-vector and immune-based platforms. Its business has been shaped by platform ambition and strategic resets.
On which exchange is HOOK stock listed?
HOOKIPA Pharma Inc. (HOOK) is associated with NASDAQ, United States, Biopharma.
What is HB-700?
HOOKIPA’s catalysts are HB-700 and the rest of its viro-immunotherapy platform, plus any partnership or strategic update.
Which conditions is HOOKIPA Pharma Inc. targeting with HB-700?
HOOKIPA Pharma Inc. is associated with oncology based on its company overview and current catalyst commentary.
How does HOOKIPA Pharma Inc. describe recent progress with HB-700?
HOOKIPA’s catalysts are HB-700 and the rest of its viro-immunotherapy platform, plus any partnership or strategic update.
What is Hookipa?
Hookipa Pharma is a biopharmaceutical company focused on immunotherapy and oncology, with a strategy that has centered on viral-vector and immune-based platforms.
What should investors watch for with Hookipa?
HOOKIPA’s catalysts are HB-700 and the rest of its viro-immunotherapy platform, plus any partnership or strategic update.